AngioDynamics, Inc. Announces Resignation of Robert A. Simpson as Senior Vice President and General Manager for Vascular Interventions and Therapies, Effective August 31, 2019
June 06, 2019 at 04:30 pm EDT
Share
On May 31, 2019, Mr. Robert A. Simpson, Senior Vice President and General Manager for Vascular Interventions and Therapies of AngioDynamics, Inc., notified the company that he will leave the company effective August 31, 2019 in order to pursue other opportunities.
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
AngioDynamics, Inc. Announces Resignation of Robert A. Simpson as Senior Vice President and General Manager for Vascular Interventions and Therapies, Effective August 31, 2019
ANGIODYNAMICS, INC. 
